Wolverine Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.28K Sell
100
-15,000
-99% -$1.04M ﹤0.01% 1471
2025
Q4
$1M Hold
15,100
0.01% 785
2025
Q3
$1.02M Hold
15,100
0.01% 733
2025
Q2
$1.32M Buy
15,100
+100
+0.7% +$7.84K 0.01% 629
2025
Q1
$1.02M Hold
15,000
0.01% 683
2024
Q4
$1.17M Hold
15,000
0.01% 647
2024
Q3
$1.01M Buy
+15,000
New +$1.23M 0.01% 704
2019
Q2
Sell
-40,000
Closed -$1.19M 1454
2019
Q1
$1.19M Buy
+40,000
New +$1.41M 0.02% 599

Other funds holding DXCM

Wolverine Asset Management's DXCM Position: Q3 2025 in Review

Wolverine Asset Management sold out of DexCom (DXCM) in Q3 2025, closing a stake of 1,572 shares — an estimated $124K sold.

Wolverine Asset Management first reported a position in DXCM in Q2 2017 and held it in 6 quarters. The position peaked at $1.6M in Q4 2018. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Wolverine Asset Management reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 1,572 DexCom shares in Q3 2025, an estimated $124K.
  • Wolverine Asset Management first reported a position in DexCom in Q2 2017 and held it in 6 quarters.
  • Wolverine Asset Management's DexCom position peaked at $1.6M in Q4 2018.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.